NEOPLASMA
Article List
Volume 57, 2010, No. 1
ISSN 0028-2685 (print)
ISSN 1338-4317 (online)
Content:
- MARIC, D. - JOVANOVIC, D. - GOLUBICIC, I. - NAGORNI-OBRADOVIC, L. - STOJSIC, J. - PEKMEZOVIC, T.: Psychological well−being in advanced NSCLC patients in Serbia: impact of sociodemographic and clinical factors. (p. 1)
- MINARIK, J. - SCUDLA, V. - BACOVSKY, J. - ZEMANOVA, M. - PIKA, T. - ORDELTOVA, M. - LANGOVA, K.: Thalidomide and bortezomib overcome the prognostic significance of proliferative index in multiple myeloma. (p. 8)
- VRANA, D. - NOVOTNY, J. - HOLCATOVA, I. - HLAVATA, I. - SOUCEK, P.: CYP1B1 gene polymorphism modifies pancreatic cancer risk but not survival. (p. 15)
- IOANNIDIS, I. - DIMO, B. - KARAMERIS, A. - VILARAS, G. - GAKIOPOULOU, H. - PATSOURIS, E. - LAZARIS, A.: Comparative study of the immunohistochemical expression of metalloproteinases 2, 7 and 9 between clearly invasive carcinomas and “in situ” trophoblast invasion. (p. 20)
- POUR, L. - SVACHOVA, H. - ADAM, Z. - MIKULKOVA, Z. - BURESOVA, L. - KOVAROVA, L. - BUCHLER, T. - PENKA, M. - VORLICEK, J. - HAJEK, R.: Pretreatment hepatocyte growth factor and thrombospondin-1 levels predict response to high-dose chemotherapy for multiple myeloma. (p. 29)
- LASABOVA, Z. - TILANDYOVA, P. - Kajo, K. - ZUBOR, P. - BURJANIVOVA, . - DANKO, J. - PLANK, L.: Hypermethylation of the GSTP1 promoter region in breast cancer is associated with prognostic clinicopathological parameters. (p. 35)
- GRZANKA, A. - PLACEK, W. - SOKOLOWSKA-WOJDYLO, M. - ZURYN, A.: Immunoelectron microscopy in mycosis fungoides and benign dermatoses. Expression of CD3, CD4 and CD7 receptors. (p. 41)
- PENTHEROUDAKIS, G. - KOSTADIMA, L. - DOVA, L. - GEORGIOU, I. - TZAVARAS, T. - VARTHOLOMATOS, G. - WIRTZ, R. - FOUNTZILAS, G. - MALAMOU-MITSI, V. - PAVLIDIS, N.: A twisted kiss: in vitro and in vivo evidence of genetic variation and suppressed transcription of the metastasis-suppressor gene KiSS1 in early breast cancer. (p. 47)
- JING, R. - CUI, M. - WANG, J. - WANG, H.: Receptor for advanced glycation end products (RAGE) soluble form (sRAGE): a new biomarker for lung cancer. (p. 55)
- GUO, W. - ZHAO, S. - YU, L. - TANG, J. - WU, G. - CHEN, J.: Expression and its clinical significance of heat shock protein gp96 in human osteosarcoma. (p. 62)
- PAVLOVIC, S. - ARTIKO, V. - SOBIC-SARANOVIC, D. - DAMJANOVIC, S. - POPOVIC, B. - JAKOVIC, R. - PETRASINOVIC, Z. - JAKSIC, E. - TODOROVIC-TIRNANIC, M. - SARANOVIC, D. - MICEV, M. - NOVOSEL, S. - NIKOLIC, N. - OBRADOVIC, V.: The utility of 99mTc-EDDA/HYNIC-TOC scintigraphy for assessment of lung lesions in patients with neuroendocrine tumors. (p. 68)
- RAHEEM, S. - ATOUM, M. - AL-HOURANI, H. - RASHEED, M. - NIMER, N. - ALMUHRIB, T.: Relationship between plasma progesterone, estradiol and prolactin concentrations and breast cancer in pre and postmenopausal women. (p. 74)
- WANG, J. - LIU, L. - PAN, S. - WANG, C. - FU, Q.: Therapeutic effect of photodynamic therapy using hematoporphyrin monomethyl ether (HMME) on human cholangiocarcinoma cell line QBC939. (p. 79)
- HU, J. - LI, Z. - LIU, W. - ZHANG, R. - LI, G. - WANG, T. - REN, J. - WU, G.: Polymorphism in heme oxygenase-1 (HO-1) promoter and alcohol are related to the risk of esophageal squamous cell carcinoma on Chinese males. (p. 86)